The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions

July 13, 2015 updated by: Yaron Har-Shai
This study evaluates the effect of breast reconstruction surgery on respiratory functions. 45 patients elected for unilateral or bilateral breast reconstruction surgery will go through respiratory function examinations a month prior to the surgery, one month after surgery and three months after surgery.

Study Overview

Detailed Description

Breast reconstruction surgery using tissue expander and implant technique is the most common breast reconstruction surgery. During this procedure, the surgeon will insert a silicone expander under the Pectoralis Major muscle. In order to fully cover the expander, the surgeon will detach the Serratus Anterior [SA] muscle from its natural attachments in the rib cage and will attach the free edges to the lateral edge of the Pectoralis Major muscle. After the wound is healed, a gradual inflation of the expander with a physiological fluid will be done by injecting the fluid into a subcutaneous filling port connected to the expander by silicone tubing. When the tissues around the expander will reach the required size, the tissue expander can be replaced by a permanent silicone implant.

The SA attachments are to the superior angle, medial border and inferior angle of the scapula and to the first to eighth ribs. Its main functions are stabilization and protraction of the scapula and turning the glenoid cavity superiorly in abduction of arms. In addition, the SA is an accessory respiratory muscle: when the scapula is stabilized, its contraction will lift the rib cage in order to help breathing. The importance of the SA in breathing has been examined since the late 19th century and until this day it is not fully agreed upon. Most studies agree that the SA major role in breathing is in deep breaths and is that the muscle is most effective for this purpose when arms are lifted.

Since breast reconstruction procedure includes detachment of the SA from the rib cage and there by canceling its respiratory function, an examination of the respiratory functions before and after the procedure is in order to determine whether or not the overall respiratory functions had been effected.

45 patients elected for unilateral or bilateral breast reconstruction surgery will go through respiratory function examinations a month prior to the surgery, one month after surgery and three months after surgery. The examinations will include the following tests: Spirometry: FVC, FEV1, MVV. Lung capacities: FRC, RV, TLC. Breathing muscle strength: MIP, MEP.

Study Type

Observational

Enrollment (Anticipated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Haifa, Israel, 34362
        • Carmel Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

patients elected for breast reconstruction surgery using tissue expander-implant technique

Description

Inclusion Criteria:

  • all subjects were elected for a unilateral or bilateral breast reconstruction using tissue expander by the Oncoplastic Committee of the plastic surgery unit in Carmel Medical Center.
  • all subjects agrees to enroll in research

Exclusion Criteria:

  • subject is in a mental or physical condition that does not allow her to go through respiratory function tests.
  • subject was found with a respiratory disfunction or disease in the first respiratory function tests.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
bilateral
bilateral breast construction candidates will go through respiratory function tests a month prior to surgery, a month after surgery and three months after surgery
FVC, FEV1, MVV, FRC, RV, TLC, MIP, MEP
unilateral
unilateral breast construction candidates will go through respiratory function tests a month prior to surgery, a month after surgery and three months after surgery
FVC, FEV1, MVV, FRC, RV, TLC, MIP, MEP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forced vital capacity -FVC
Time Frame: a month prior to surgery
Forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort
a month prior to surgery
Forced expiratory volume at one second -FEV1
Time Frame: a month prior to surgery
Volume that has been exhaled at the end of the first second of forced expiration
a month prior to surgery
Maximum voluntary ventilation-MVV
Time Frame: a month prior to surgery
Maximal voluntary ventilation: volume of air expired in a specified period during repetitive maximal effort
a month prior to surgery
Functional residual capacity-FRC
Time Frame: a month prior to surgery
Functional residual capacity: the volume in the lungs at the end-expiratory position
a month prior to surgery
Residual volume -RV
Time Frame: a month prior to surgery.
Residual volume: the volume of air remaining in the lungs after a maximal exhalation.
a month prior to surgery.
Total lung capacity-TLC
Time Frame: a month prior to surgery.
Total lung capacity: the volume in the lungs at maximal inflation, the sum of VC and RV.
a month prior to surgery.
Maximal inspiratory pressure-MIP
Time Frame: a month prior to surgery.
Maximal inspiratory pressure (MIP) is the maximal pressure that can be produced by the patient trying to inhale through a blocked mouthpiece
a month prior to surgery.
Maximal expiratory pressure-MEP
Time Frame: a month prior to surgery.
Maximal expiratory pressure (MEP) is the maximal pressure measured during forced expiration (with cheeks bulging) through a blocked mouthpiece after a full inhalation.
a month prior to surgery.
Forced vital capacity -FVC
Time Frame: a month after surgery
Forced vital capacity: the determination of the vital capacity from a maximally forced
a month after surgery
Forced vital capacity -FVC
Time Frame: three months after surgery
Forced vital capacity: the determination of the vital capacity from a maximally forced
three months after surgery
Forced expiratory volume at one second -FEV1
Time Frame: a month after surgery
Volume that has been exhaled at the end of the first second of forced expiration
a month after surgery
Forced expiratory volume at one second -FEV1
Time Frame: three months after surgery
Volume that has been exhaled at the end of the first second of forced expiration
three months after surgery
Maximum voluntary ventilation-MVV
Time Frame: a month after surgery
Maximal voluntary ventilation: volume of air expired in a specified period during repetitive maximal effort
a month after surgery
Maximum voluntary ventilation-MVV
Time Frame: three months after surgery
Maximal voluntary ventilation: volume of air expired in a specified period during repetitive maximal effort
three months after surgery
Functional residual capacity-FRC
Time Frame: a month after surgery
Functional residual capacity: the volume in the lungs at the end-expiratory position
a month after surgery
Functional residual capacity-FRC
Time Frame: three months after surgery
Functional residual capacity: the volume in the lungs at the end-expiratory position
three months after surgery
Residual volume -RV
Time Frame: a month after surgery
Residual volume: the volume of air remaining in the lungs after a maximal exhalation.
a month after surgery
Residual volume -RV
Time Frame: three months after surgery
Residual volume: the volume of air remaining in the lungs after a maximal exhalation.
three months after surgery
Total lung capacity-TLC
Time Frame: a month after surgery.
Total lung capacity: the volume in the lungs at maximal inflation, the sum of VC and RV.
a month after surgery.
Total lung capacity-TLC
Time Frame: three months after surgery.
Total lung capacity: the volume in the lungs at maximal inflation, the sum of VC and RV.
three months after surgery.
Maximal inspiratory pressure-MIP
Time Frame: a month after surgery
Maximal inspiratory pressure (MIP) is the maximal pressure that can be produced by the patient trying to inhale through a blocked mouthpiece
a month after surgery
Maximal inspiratory pressure-MIP
Time Frame: three months after surgery.
Maximal inspiratory pressure (MIP) is the maximal pressure that can be produced by the patient trying to inhale through a blocked mouthpiece
three months after surgery.
Maximal expiratory pressure-MEP
Time Frame: a month after surgery.
Maximal expiratory pressure (MEP) is the maximal pressure measured during forced expiration (with cheeks bulging) through a blocked mouthpiece after a full inhalation.
a month after surgery.
Maximal expiratory pressure-MEP
Time Frame: three months after surgery.
Maximal expiratory pressure (MEP) is the maximal pressure measured during forced expiration (with cheeks bulging) through a blocked mouthpiece after a full inhalation.
three months after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Yaron Har-Shai, Proffesor, Carmel Medical Center-Israel

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Anticipated)

August 1, 2017

Study Completion (Anticipated)

August 1, 2017

Study Registration Dates

First Submitted

June 16, 2015

First Submitted That Met QC Criteria

July 7, 2015

First Posted (Estimate)

July 8, 2015

Study Record Updates

Last Update Posted (Estimate)

July 15, 2015

Last Update Submitted That Met QC Criteria

July 13, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • CMC-15-0029-CTIL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Reconstruction

Clinical Trials on respiratory function tests

3
Subscribe